Perrigo (PRGO) Declares $0.145 Quarterly Dividend; 0.6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Guggenheim Cuts PT On Perrigo (PRGO) By 30%
April 27, 2016 6:37 AM EDTGuggenheim analyst, Louise Chen, thinks Perrigo Co. (NYSE: PRGO) stock could experience downward pressure ahead of 1Q16 earnings but that earnings visibility going forward is likely to improve. Due to the executive departure, she cut her PT from $185 to $125 but maintained a Buy... More
S&P Downgrades Perrigo (PRGO) to 'BBB-'; Sees Weakness in High-Margin Business
April 26, 2016 12:14 PM EDTStandard & Poor's Ratings Services lowered all of its ratings on Perrigo Co. plc (NYSE: PRGO), including the corporate credit rating to 'BBB-' from 'BBB'. The outlook is stable. Reported debt outstanding as of Dec. 31, 2015 was about $6 billion.
"The downgrade reflects our expectation for weakness in Perrigo's high-margin generic pharmaceutical business, largely resulting from intensifying competition and lower pricing, and a further expected decline in the recently acquired European branded consumer business," said Standard & Poor's credit analyst Gerald Phelan. "As a result, we now forecast adjusted debt-to-EBITDA in the mid-3x area over... More
